Study of Dysarthria, Swallowing Disorders and Respiratory in Parkinson's Disease
Trial
N/A
Completed
May 17, 2017
A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Trial
Phase 3
Completed
May 16, 2017
A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
Trial
Phase 3
Completed
May 16, 2017
Cardiovascular Events in Parkinson's Disease Patients
Trial
N/A
Completed
May 15, 2017
Parkinson's Diseases Susceptibility Genes and Pesticides
Trial
N/A
Completed
May 15, 2017
Dopaminergic Modulation of Declarative Memory
Trial
Phase 4
Completed
May 11, 2017
Education in Therapy of Parkinson's Disease
Trial
N/A
Completed
May 11, 2017
Assessment of Three-dimensional Vision Alteration in Parkinson Disease
Trial
N/A
Completed
May 11, 2017
LRRK2 Mutation and Parkinson's Disease
Trial
Phase 1
Terminated
May 10, 2017
Non-invasive Measurement of Brain Oxygen Levels in People With Subthalamic Deep Brain Stimulators
Trial
N/A
Completed
May 7, 2017
Apomorphine in Parkinson's Disease Patients With Visual Hallucinations
Trial
Phase 2
Unknown
May 2, 2017
Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist
Trial
N/A
Unknown
May 2, 2017
Temporal Relationship Between Motor Fluctuations and Nonmotor Fluctuations
Trial
N/A
Recruiting
May 2, 2017
Swallowing and Breathing Exercises for Dysphagia in Parkinson Disease
Trial
N/A
Completed
April 26, 2017
Hub and Spoke, Comparative Outcomes for Parkinson's Disease Treated With Deep Brain Stimulation
Trial
N/A
Withdrawn
April 26, 2017
Investigating Therapies for Freezing of Gait
Trial
N/A
Unknown
April 24, 2017
Implantable Systems Performance Registry
Trial
N/A
Completed
April 20, 2017
Expanded Access of Pimavanserin for Patients With PD Psychosis
Trial
N/A
Approved for marketing
April 17, 2017
Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease
Trial
Phase 1
Unknown
April 17, 2017
Effect of Food on Opicapone
Trial
Phase 1
Completed
April 16, 2017